Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

ABPI

UK trade associations form new life sciences lobbying group

January 11, 2011 Research and Development, Sales and Marketing ABHI, ABPI, BIA, BIVDA, LifeSciencesUK, lobbying

Four industry trade associations including pharma body the ABPI have banded together to form a new lobbying group representing life …
News

Savient plays down gout drug manufacturing problems

January 11, 2011 Manufacturing and Production, Sales and Marketing Krystexxa, Savient, biologic manufacturing, gout, manufacturing compliance, pegloticase

Savient Pharmaceuticals has reported that some production batches of Krystexxa, its recently-approved second-line treatment for gout, have failed to meet …
News
Food and Drug Administration (FDA)

FDA launches online transparency initiative

January 11, 2011 Medical Communications, Research and Development, Sales and Marketing FDA, Joshua Sharfstein, transparency

The FDA has launched a new online resource to increase the transparency of its processes and help save companies time …
News

Sanofi boosts emerging markets leadership team

January 11, 2011 Sales and Marketing Brazil, China, Heraldo Marchezini, Japan, Jeremy Moulding Russia, Patrick Aghanian, Sanofi-Aventis, Thomas Kelly, appointments, emerging markets, sales and marketing

Sanofi-Aventis has bolstered its emerging markets team with the appointment of four senior managers. They are Patrick Aghanian, Thomas Kelly, …
Appointment
GlaxoSmithKline’s H1N1 vaccine Pandemrix

Doctors use GSK’s Pandemrix as seasonal flu vaccines fall short

January 10, 2011 Sales and Marketing GSK, GlaxoSmithKline, Pandemrix, flu, h1n1, influenza, vaccines

Doctors may have to use last year’s stock of the H1N1 vaccine Pandemrix as the government admits there are some …
News

Sanofi’s Genzyme takeover bid focuses on Campath

January 10, 2011 Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, biotech acquisition

Sanofi-Aventis and Genzyme have come back to the negotiation table to discuss the potential of Genzyme’s multiple sclerosis drug Campath. …
News

Dendreon eyes late 2011 European cancer vaccine filing

January 10, 2011 Sales and Marketing Cancer, Denreon, Provenge, cancer vaccine, sipuleucel, vaccines

Dendreon Group is to seek marketing authorisation in Europe for the world’s first immunotherapy cancer vaccine in late 2011 or …
News

Cephalon’s Paul Harmon joins IPHA board

January 10, 2011 Sales and Marketing Cephalon, IPHA, Paul Harmon, appointment, sales and marketing

Cephalon’s Paul Harmon has been elected to the prescription medicines division strategy board of Irish pharma association IPHA, a role …
Appointment

Regulators fast-track Merck’s hepatitis C drug boceprevir

January 7, 2011 Sales and Marketing Merck & Co, boceprevir, hepatitis C, telaprevir

Merck’s new oral hepatitis C drug boceprevir will receive fast track reviews from both the FDA and the EMA after …
News

Sanofi workers strike in France

January 7, 2011 Research and Development, Sales and Marketing Sanofi, Sanofi-Aventis, strikes, unions

Sanofi-Aventis workers have gone on strike in France as the company looks to cut jobs. Nine unions representing workers at …
News
Avastin (bevacizumab) packs

Study highlights Avastin heart failure risk

January 6, 2011 Research and Development, Sales and Marketing Roche, avastin, bevacizumab, breast cancer

A new study confirms that Roche’s Avastin is linked to a small but significant increased risk of heart failure in …
News

Biogen Idec appoints new head of R&D

January 6, 2011 Research and Development, Sales and Marketing Biogen IDEC, Douglas Williams, Steven Holtzman, appointment, research and development, sales and marketing

Biogen Idec has a new head of research and development, appointing Douglas Williams to oversee its global operations. The position …
Appointment

Janssen’s Invega wins schizoaffective approval in Europe

January 6, 2011 Sales and Marketing Invega, Janssen, paliperidone ER, schizoaffective disorder, schizophrenia

Janssen’s Invega has become the first drug to be licensed in Europe to treat schizoaffective disorder. European regulators approved Invega …
News

Leukaemia drug fast-tracked by NICE

January 6, 2011 Sales and Marketing Bendamustine, Levact, NICE, Napp, chronic lymphocytic leukaemia, leukaemia

A treatment for patients with the most common form of leukaemia has been fast tracked by NICE because of strong …
News

Bayer submits new Xarelto indications for European approval

January 6, 2011 Sales and Marketing Bayer, DVT, Xarelto, atrial fibrillation, deep vein thrombosis, pulmonary embolism, rivaroxaban, stroke prevention

Bayer is seeking European regulatory approval for a batch of new indications for its oral anticoagulant Xarelto. The company is …
News
The Gateway to Local Adoption Series

Latest content

China approves fruquintinib combination for kidney cancer

May 29, 2026

BIOTRONIK, Charité and GHCF launch digital cardiology partnership

May 28, 2026

Endometriosis study begins recruitment in UK hospitals

May 28, 2026

MHRA authorises donidalorsen for hereditary angioedema prevention

May 27, 2026

Partnership aims to expand early access to medicines

May 26, 2026